IN BRIEF: GENinCode raises GBP4.0 million via placing and subscription
14th Feb 2025 19:10
GENinCode PLC - Oxford, England-based genomic testing company focused on the prevention of cardiovascular disease - Raises GBP4.0 million via placing and subscription of around 108.1 million shares at 3.7 pence each. Includes subscription by directors of the business for 4.7 million shares. GENinCode also hopes to raise GBP0.5 million via a retail offer at the same price. Proceeds will be sufficient for at least 12 months and will be used to fund the completion of the US regulatory and reimbursement program, drive commercialisation in the US, expand activities in the UK and Europe, positioning the company on a pathway to breakeven/profitability over the medium term. Read More